Introduction
adherens junctions, the transcellular pathway and the vascular pathway (Maes et al., 2019c; Simeonova et al., 2018; Vojdani and Vojdani, 2019) . Nevertheless, various pathophysiological conditions are accompanied by a breakdown of one or more components of this barrier thereby allowing increased translocation of LPS or Gram-negative bacteria into the mesenteric lymph nodes and beyond into the blood circulation 2012a; 2019c; 2019a; Morris et al., 2016; Simeonova et al., 2018; Slyepchenko et al., 2017) . Once translocated into the lymph nodes or beyond, IgA and IgM responses to the LPS and other antigens of Gram-negative bacteria may be mounted . Moreover, pathogen-associated molecular patterns (PAMPs) including LPS of Gram-negative bacteria may activate the Toll-Like Receptor (TLR)-4 complex which causes downstream activation of immune-inflammatory and oxidative stress pathways as indicated by increased levels of pro-inflammatory cytokines and reactive oxygen species including peroxides and nitric oxide (Lucas & Maes, 2013; Lucas et al., 2015) . As such, LPS or bacterial translocation may cause immune, inflammatory and oxidative stress responses. Furthermore, injection of even minimal amounts of LPS to human volunteers may decrease mood and induce anxiety (Eisenberger et al., 2010; Grigoleit et al., 2011) , while, in animal models, repeated administration of LPS induces depressive-like behaviors as well as neuro-inflammatory responses (Kubera et al., 2013; Rodrigues et al., 2018) . There are now also data that alterations in microbial composition in the gut, indicating gut dysbiosis, may occur in psychiatric disorders including MDD (Aizawa et al., 2016; Jiang et al., 2015; Lin et al., 2017; Naseribafrouei et al., 2014) and BD (Nguyen et al., 2018) . Finally, breakdown of the gut barrier, especially the paracellular and vascular pathways may cause increased gut permeability (leaky gut) thereby inducing increased bacterial or LPS translocation and consequently increased IgM/IgA-mediated immune responses against Gram-negative gut commensal bacteria 2019c) . However, it remains unknown whether IgA/IgM responses to Gram-negative bacteria are also increased in BD patients during an acute depressive episode and whether there are differences between BP1 and BP2 patients. Hence, the current study was conducted to assess the IgM and IgA responses to LPS of H. alvei, P. aeruginosa, M. morganii, P. putida, C. koseri, and K. pneumoniae in patients with BP1 and BP2, versus MDD and healthy controls. The specific hypotheses are that BD and MDD patients show increased IgM/IgA responses to these Gram-negative bacteria as compared with controls.
Subjects and Methods

Subjects
One hundred and forty participants took part in the study and they were categorized in the following groups: BP1 (n=29); BP2 (n =37); MDD (n=44); and healthy controls (n =30). Patients with BP depression and MDD were recruited at the clinics of the last author in Belgium, while healthy controls consisted of family members, friends and employees of the clinics and affiliated institutions. The enrolled subjects were between 18 and 71 years of age, male and female, of Caucasian descent. The socio-economic status of all participants was comparable between subjects, namely middle-higher class in a country with minor differences between classes.
Diagnoses of BP1, BP2, and MDD were made using the criteria of the DSM-IV-TR (First et al., 2002 ) using the structured clinical interview for the DSM-IV. We additionally measured the severity of illness using the Hamilton Depression Rating Scale (HAM-D) (Hamilton, 1960) and only patients in an acute depressive episode were included while we used a score above 15 on the HAM-D instrument as an inclusion criterion. The presence of "melancholia" was defined based on the DSM-IV-TR criteria across MDD, BP1, and BP2 and, as such, we included 27 melancholia patients, namely 4 with BP2, 8 with BP1 and 15 with MDD. Exclusion criteria for controls and patients are a) neuro-inflammatory disease including Alzheimer's disease, Parkinson's disorder, multiple sclerosis and stroke; b) (auto)immune disorders including type 1 diabetes, COPD, chronic kidney disease, rheumatoid arthritis or inflammatory bowel disease; and c) allergic conditions 2 months prior to the study; c) subjects who had a lifetime history of using immunomodulatory drugs (such as glucocorticoids) and subjects who used therapeutic dosages of omega-3 polyunsaturated fatty acids of antioxidants; and d) subjects with a body mass index (BMI) above 30. Patients were excluded when they had suffered from another axis-1 psychiatric disorder, except for MDD and BP, and from chronic MDD (that is > 2 year). Controls were excluded for any lifetime or current diagnosis of axis-1 psychiatric disorders. The study has been approved by the ethical committee of the Medical University of Plovdiv (2/19.04.2018). All subjects gave written informed consent after the study has been explained to them and before their enrolment into the study.
Materials and methods
Fasting peripheral blood was sampled from all subjects in the morning hours (8.00 -10.00 a.m.) and collected serum was frozen at -80 o C until thawed for assay of IgA and IgM directed against the LPS of Gram-negative bacteria including H. alvei, P. aeruginosa, M. morganii, P. putida, C. koseri, and K. pneumoniae . A description of the measurements of IgA/IgM antibodies directed to LPS of those Gram-negative bacteria is given somewhere else in detail (Geffard et al., 2002; Maes et al., 2008) . The inter-assay coefficients of variation (CV) were < 10%. The assays of IgG responses to oxidized LDL and peroxides have been described previously (Maes et al., 2010) . IgG to oxLDL was measured by means of an enzyme immunoassay )EIA; Biomedica Medizinproducte GmbH & Co; A-1210 Wien, Austria; Cat. no: BI-20032 ; 12 x 8 tests; conventional 96-well ELISA format(. The standard range is 37-1200 mU/ml, the detection limit of the assay is 48 mU/ml and the inter-assay coefficient of variation 4.0%. Peroxides were determined using a colorimetric assay Oxystat )Biomedica Medizinproducte GmBH & Co KG, A-1210 Wien( for the quantitative determination of peroxides in EDTA plasma )Cat No BI-5007(. The detection limit of the assay is 7 µmol/l and the interassay CV is 5.1%.
Statistics
We used analysis of contingency tables (Chi-square test) to assess associations between categorical variables and analysis of variance (ANOVAs) to assess differences in continuous variables between groups. Correlations among variables were checked with Spearman's rank-order correlation analyses and Pearson's product-moment correlation coefficients. Multiple regression analysis was performed to assess the significant predictors (including the IgM/IgA responses) of scale variables (including the severity of illness and oxidative stress variables). Multivariate GLM analysis was employed to assess the effects of diagnosis as explanatory variables (three groups: controls, and depression with and without melancholic features; and four groups: controls, BP1, BP2 and MDD) on the IgM and IgA responses to Gram-negative bacteria (dependent variables) while adjusting for background variables such as age and sex. Consequently, we performed tests for between-subject effects to check effects of diagnosis on all IgM and IgA responses separately and employed protected pairwise posthoc tests to assess pairwise differences between the diagnostic groups. Binary and multinomial logistic regression analysis was used to assess the best predictors of diagnostic classes and computed Odds ratios with 95% confidence intervals. OD values of the IgM and IgA responses were first Ln transformed (to normalize the data distribution) and then processed in z transformation. We also computed an integrated index of bacterial translocation as z (sum of z values of Ln IgM to the 6 Gram-negative bacteria + sum of z values of Ln IgA to the 6 Gram-negative bacteria). All statistical tests were two-tailed and a p-value of 0.05 was used for statistical significance. All statistical analyses were performed using Statistica 12, Stata SE-64, and IBM SPSS windows version 25. Table 1 shows the socio-demographic data of the participants divided into 4 study groups (controls, MDD, BP1, and BP2). There were no significant differences in age, sex ratio, BMI between the 4 study groups. There were somewhat more subjects with TUD in the BP2 patient group than in normal control. Significantly more patients with melancholia were found in BP1 than in MDD and significantly more patients with treatment-resistant depression in MDD were detected than in BP2. There were no significant differences in severity of illness and number of episodes between the three patient subgroups. This table also shows the mean values of IgG against oxidized LDL and peroxide levels in the 4 groups. IgG to oxidized LDL was significantly greater in BP1 and MDD patients as compared with controls and higher in MDD than in BP2 patients.
Results
Socio-demographic data
There were no significant differences in IgG to oxidized LDL between BP1 and BP2 patients.
There was a trend towards higher peroxide levels in MDD as compared with controls. Gram-negative bacteria after adjusting for sex and age. IgA responses to H. alvei and M. morganii were significantly higher in BP1 and MDD than in controls. IgA responses to P. aeruginosa were significantly higher in all patient groups than in controls. IgA responses to P. putida and C. koseri were significantly higher in BP1 than in MDD and BP2 patients and controls. IgA responses to K. pneumoniae are significantly higher in BP1 than in controls. This table shows also the differences between controls and non-melancholic and melancholic patients. IgA responses to H. alvei were significantly higher in both depressed groups than in controls. IgA responses to P. aeruginosa were significantly higher in non-melancholic patients than controls. IgA responses to M. morganii, P. putida, C. koseri, and K. pneumoniae were higher in melancholia than in controls while those with non-melancholic depression occupied an intermediate position. Table 3 shows the estimated marginal mean values (in z scores) of the IgM responses after adjusting for sex and age. IgM responses to H. alvei were significantly higher in BP1 and MDD than in controls and BP2. IgM responses to P. aeruginosa and P. putida were significantly higher in all patient groups as compared with controls. IgM responses to M. morganii and C. koseri and the integrated index of IgM/IgA to all bacteria were significantly higher in BP1 than in BP2 and controls and higher in MDD than in controls. IgM to K. pneumoniae was higher in BP1 than in controls.
Differences in IgA responses to LPS between diagnostic groups.
Differences in IgM responses to LPS between diagnostic groups.
GLM analysis #2 shows that there was a significant effect of the diagnosis melancholia versus non-melancholia or controls on the IgM values, although the effect size was only 0.089.
There were significant effects of this diagnosis on the IgM responses, except C. koseri and K. pneumoniae. Best prediction of diagnoses using IgM/IgA responses. Table 5 shows the results of binary and multinomial logistic regression analysis with diagnosis as dependent variables. Binary regression analysis discriminating mood disorders (MDD plus BD) from controls showed that mood disorders were best predicted (χ2=28.60, df=2, p<0.001) by both IgA and IgM to P. aeruginosa with a Nagelkerke value of 0.286. Multinomial regression #2 shows the discrimination of controls, BP1, BP2 and MDD using the 6 IgM and 6 IgA responses.
We found that IgM to M. morganii (χ2=18.60, df=3, p<0.001), IgA to M. morganii (χ2=14.61, df=3, p=0.002), IgM to P. aeruginosa (χ2=11.85, df=3, p=0.008) and age (χ2=9.28, df=3, p=0.026) significantly (χ2=54.35, df=12, p<0.001) discriminated the 4 groups with a Nagelkerke value of 0.344. Table 5 shows that BP2 and MDD were discriminated from controls by IgA to M. morganii and IgM to P. aeruginosa. BP1 was best discriminated from controls by IgA to M. morganii. BP1 was best discriminated from BP2 and MDD by IgM to M. morganii.
The second multinomial logistic regression in Table 5 examines the discrimination between controls, and patients with and without melancholic depression. We found that IgM to C. koseri (χ2=23.15, df=2, p<0.001), IgA to P. aeruginosa (χ2=11.97, df=23, p=0.003), and IgM to P. aeruginosa (χ2=16.14, df=2, p<0.001) significantly (χ2=50.46, df=6, p<0.001) discriminated those 3 groups with a Nagelkerke value of 0.375. IgA to C. koseri best predicted melancholia versus controls and non-melancholia, while both IgA and IgM to P. aeruginosa predicted nonmelancholic depression versus controls. r=0.194, p=0.042) . IgG levels directed against oxidized LDL were best predicted (18.9% of the variance) by IgM to P. aeruginosa and IgA H. alvei. We found that 32.6% of the variance in peroxide levels was associated with sex and IgM to P. aeruginosa. There were no significant associations between any of the IgM values and the HAM-D total score.
Prediction of severity of illness and oxidative biomarkers.
Discussion
The first major finding of this study is that a) IgA/IgM responses to the LPS of gut commensal bacteria were positively associated with mood disorders (MDD and BD combined) as compared to healthy controls; b) IgA/IgM responses were higher in MDD and BP1 than in controls, while BP2 occupied an intermediate position; c) IgA responses to P. putida and C. koseri were higher in BP1 than in MDD, BP2, and controls; and d) IgM responses to H. alvei, M. morganii and C. koseri were higher in BP1 than in BP2 and controls. These findings extend those of previous studies which showed increased IgA/IgM responses to the LPS of Gram-negative bacteria in MDD 2012a) . As explained in the Introduction, these findings indicate increased gut dysbiosis and bacterial translocation of commensal gut bacteria through the gut wall, thus supporting the evidence that increased gut permeability is a characteristic of MDD 2012a) . Moreover, the results show that the same pathways play a role in BP1 depression and that patients with the latter type of depression may show more bacterial translocation than MDD patients. Recent research papers reported changes in the microbiome in MDD (Aizawa et al., 2016; Jiang et al., 2015; Lin et al., 2017; Naseribafrouei et al., 2014) and BD as well (Nguyen et al., 2018) . There is also some evidence that increased gut permeability is associated with BP depression (Dickerson et al., 2017; Severance et al., 2010) and with chronic MDD 2012a) . For example, the IgM responses to LPS of Gram-negative bacteria were significantly increased in patients suffering from chronic depression (duration > 2 years) when compared to patients with non-chronic depression and controls (Maes et al., 2012a) . Nevertheless, patients with chronic MDD or BD were excluded from the present study.
The data of the current study add to the differentiation of MDD, BP1, and BP2. Previously it was observed that signs of protein oxidation as measured using advanced protein oxidation products (AOPPs) are significantly higher in BP1 and MDD patients than in BP2 patients and controls (Maes et al., 2019a) while superoxide dismutase (SOD1) and lipid peroxide markers including malondialdehyde (MDA) were higher in MDD than in BP1, which in turn showed higher values than BP2. Recently, we also detected significant differences in immune profiles between MDD and BD with increased levels of interleukin (IL)-1β, IL-10, IL-12, tumor necrosis factor (TNF)-α, and soluble TNF receptor (TNFR)-1 in MDD versus BD and increased IL-6, IL-18, IL-33, sTNFR-2, ST2 (ILR Like 1) and KLOTHO in BD as compared with MDD (Brunoni et al., submitted). On the other hand, no significant differences in immune profiles (including IL-6, sIL-6R, sIL-2R, acute-phase proteins) or oxidative stress (aldehyde formation) could be found between MDD and BD (Maes, 1995; Maes et al., 1997; Sowa-Kućma et al., 2018a) . All in all, the current study as well previous studies indicate that the immune pathophysiology of MDD and BD and BP1 and BP2 may be different.
The second major finding of the study is that there are signs of increased bacterial translocation in patients with melancholia as compared with patients without melancholia and controls. To the best of our knowledge, this is the first study showing increased bacterial translocation in MDD/BD patients with melancholia. Previously, there were some reports that melancholia is accompanied by more pronounced aberrations in immune and oxidative stress pathways as compared with non-melancholic depression including increased levels of sIL-6R, aldehyde formation, and TNF-α signaling (Siwek et al., 2017; Sowa-Kućma et al., 2018b , 2018a ).
More specifically, in the current study, we found that the IgA (but not IgM) responses to M. morganii, P. putida, C. koseri, and K. pneumoniae were significantly higher in MDD/BD patients with melancholia as compared with those without melancholia. Likewise, the HAM-A score was significantly associated with IgA (but not IgM) responses to all 6 Gram-negative bacteria but most strongly with C. koseri. During immune responses, IgM antibodies are the first antibodies to be produced followed by IgA antibodies. Both natural or innate IgM (produced by B1 or primitive B cells) and adaptive IgM (produced by B2 B cells) antibodies play a key role in the host defence against pathogens, including intra-cellular bacteria, while natural IgM have additional antiinflammatory and anti-oxidative properties (Maes et al., 2019c; Racine & Winslow, 2009) . In this respect, it is interesting to note that natural B1 cells residing in the peritoneum contribute to the long-term maintenance of IgM levels and protection against bacterial infections (Racine & Winslow, 2009 ). B1 cells in the lamina propria may undergo class-switching to IgA secretory cells leading to antibody diversification and more complete protection against pathogenic and commensal microorganisms (Cerutti, 2008; Cerutti & Rescigno, 2008; Twigg, 2005) . IgA antibodies play a key role in immune exclusion and immune protection and offer another layer of protection against intestinal bacteria including at mucosal surfaces (Cerutti, 2008) . All in all, it appears that depression in patients with MDD/BD is associated with natural/adaptive IgM and IgA responses to Gram-negative bacteria, while melancholia is associated with IgA responses only.
This could suggest that patients with BD and unipolar depression are at increased risk to develop melancholia when they show relatively lower IgM levels and thus a lowered protection. Future prospective research projects should further examine the role of IgM and IgA responses to microorganisms in both depression and melancholia.
The third major finding of this study is that indices of oxidative stress in MD/BD are predicted by increased bacterial translocation. Thus, IgM levels to P. aeruginosa and H. alvei predicted increased IgG-mediated autoimmune responses to oxidized LDL, while IgM to P. putida predicted increased peroxide levels. Such findings suggest that translocation of LPS or Gramnegative bacteria may not only drive immune responses but also activated oxidative stress pathways and autoimmune responses to oxidative specific epitopes in both MDD and BD. Importantly, we found that both MDD and BD are accompanied by higher IgG levels to oxidized LDL while the latter is also a characteristic of coronary artery disease (CAD) (Maes et al., 2010; 2011b) . These associations are of particular interest because IgG levels to oxidized LDL are directly associated with the development of CAD while the latter condition is frequently comorbid with MDD and BD (Maes et al., 2010) . As such, increased bacterial translocation in mood disorders may underpin at least in part the pathophysiology of CAD (Maes et al., 2011b) .
Epidemiological studies reported links between depressive symptoms and increased carotid artery intima-media thickness, a marker of accelerated vascular aging (Elovainio et al., 2005) . A study on intrahepatic sinusoidal endothelial dysfunction after LPS administration showed increased dysfunction and oxidative stress (La Mura et al., 2014) .
As described in the Introduction increased levels of LPS due to bacterial translocation may cause depressive-like behaviors . Recent studies also suggest that changes in the microbiome including dysbiosis may lead to behavioral and mood changes such as anxiety, exaggerated stress responses (Sudo et al., 2004) , and reduced social motivation (Dinan & Cryan, 2013) . Administration of small amounts of LPS may result in depression and anxiety symptoms, impaired cognition and an increased sense of pain in viscera (Wegner et al., 2015) . It is also possible that increased translocation of LPS may explain the development of melancholia symptoms. In this respect, animal models show that chronic and/or repeated administration of LPS may induce long-lasting changes in neuro-oxidative and neuro-immune pathways (similar as those detected in MDD) in association with anhedonia, a key symptom of melancholia (Kubera et al., 2013; Rodrigues et al., 2018) . LPS may cause depressive-like or melancholia symptoms via different routes, including PAMP-activation of the TLR complex with consequent production of reactive oxygen and nitrogen species and pro-inflammatory cytokines leading to oxidative and nitrosative stress as well as activated immune-inflammatory pathways (Lucas & Maes, 2013; Lucas et al., 2015) . As reviewed previously, these are three intertwined pathways that underpin the pathophysiology of MDD and BD (Maes, 1995; Moylan et al., 2013; .
The results of the present study should be discussed with respect to its limitations. First, this is a case-control study that does not allow making inferences on causal relationships. Second, different environmental factors that may change the microbiome were not controlled for including the type of diet and exercise. Thirdly, it would have been interesting if we had assayed immuneinflammatory biomarkers as well as the gut microbiome.
In conclusion, this study shows that not only MDD but also BP1 is accompanied by 
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